Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Gyre Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of F351 (Hydronidone) for the treatment of MASH-associated fibrosis in the United States. It is also advancing a diverse pipeline in the PRC through its controlling interest in Gyre Pharmaceuticals, including therapeutic expansions of ETUARY, and development programs for F573, and F528. F351 is a structural derivative of ETUARY. F573 is its clinical-stage product candidate for the treatment of acute/acute-on-chronic liver failure (ALF/ACLF) in Phase 2 clinical trials in the PRC. F528 is a preclinical-stage candidate targeting chronic obstructive pulmonary disease. It is focused on commercializing therapies for the treatment of pulmonary fibrosis through its two therapeutic products: ETUARY (pirfenidone) and nintedanib. It is also focused on commercializing the avatrombopag product and discovery and development of targeted protein degrader and degrader antibody conjugate therapies.
Find out what a historical investment in Gyre Therapeutics Inc would be worth today using our GYRE stock calculator.
Buying GYRE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Gyre Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in GYRE
What is the ticker symbol of Gyre Therapeutics Inc?
The ticker symbol for Gyre Therapeutics Inc is GYRE.
How much is one share of GYRE?
One share of GYRE is valued at $4.52 as of 20 November 2026.
What is the market capitalisation of Gyre Therapeutics Inc GYRE?
As of 20 November 2026 Gyre Therapeutics Inc has a market cap of $475.02M.
What is the 52-week high for Gyre Therapeutics Inc stock?
The Gyre Therapeutics Inc 52-week high stock price is $9.14.
What is the 52-week low for Gyre Therapeutics Inc stock?
The Gyre Therapeutics Inc 52-week low stock price is $3.97.
Can I buy GYRE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GYRE shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GYRE on Stake
Buy GYRE from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of GYRE from only US$10 with fractional shares